Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

O2-Glycosylated Diazeniumdiolates As Nitric Oxide (NO)-Releasing Prodrugs

  • Read more about O2-Glycosylated Diazeniumdiolates As Nitric Oxide (NO)-Releasing Prodrugs
US Patent 7,081,524
Filed on 2005-04-12

A Novel Antiproliferative Factor and Methods of Use In Bladder Cancer

  • Read more about A Novel Antiproliferative Factor and Methods of Use In Bladder Cancer
US Application 10/882,586
Filed on 2004-07-01

Cyanovrin Conjugates and Matrix-Anchored Cyanovrin and Nti-Cyanovirin and Related Compositions and Methods of Use

  • Read more about Cyanovrin Conjugates and Matrix-Anchored Cyanovrin and Nti-Cyanovirin and Related Compositions and Methods of Use
United Kingdom
00913869.4
Filed on 2000-03-10

Cyanovrin Conjugates and Matrix-Anchored Cyanovrin and Nti-Cyanovirin and Related Compositions and Methods of Use

  • Read more about Cyanovrin Conjugates and Matrix-Anchored Cyanovrin and Nti-Cyanovirin and Related Compositions and Methods of Use
Belgium
00913869.4
Filed on 2000-03-10

Cyanovrin Conjugates and Matrix-Anchored Cyanovrin and Nti-Cyanovirin and Related Compositions and Methods of Use

  • Read more about Cyanovrin Conjugates and Matrix-Anchored Cyanovrin and Nti-Cyanovirin and Related Compositions and Methods of Use
Switzerland
00913869.4
Filed on 2000-03-10

Cyanovrin Conjugates and Matrix-Anchored Cyanovrin and Nti-Cyanovirin and Related Compositions and Methods of Use

  • Read more about Cyanovrin Conjugates and Matrix-Anchored Cyanovrin and Nti-Cyanovirin and Related Compositions and Methods of Use
France
00913869.4
Filed on 2000-03-10

Cyanovrin Conjugates and Matrix-Anchored Cyanovrin and Anti-Cyanovirin and Related Compositions and Methods of Use

  • Read more about Cyanovrin Conjugates and Matrix-Anchored Cyanovrin and Anti-Cyanovirin and Related Compositions and Methods of Use
Germany
00913869.4
Filed on 2000-03-10

AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY

  • Read more about AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY
US Patent 7,939,635
Filed on 2005-02-16

NITROXYL PROGENITORS IN THE TREATMENT OF HEART FAILURE

  • Read more about NITROXYL PROGENITORS IN THE TREATMENT OF HEART FAILURE
US Patent 7,863,262
Filed on 2005-03-31

A New Target for Angiogenesis and Anti-Angiogenesis Therapy

  • Read more about A New Target for Angiogenesis and Anti-Angiogenesis Therapy
Japan
2004-551922
Filed on 2005-05-09

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1041
  • Page 1042
  • Page 1043
  • Page 1044
  • Page 1045
  • Page 1046
  • Page 1047
  • Page 1048
  • Page 1049
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health